Skip to main content
    A

    Anixa Biosciences Inc (ANIX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.55
    -0.07 (-2.67%)

    Market Cap: $88.65M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Anixa Biosciences Inc (ANIX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Anixa Biosciences (ANIX) has a latest price of $2.55 on Nov 17, 2026, 53.3% below its 52-week high of $5.46. Its price fell 41.9% over the past 12 months. The month-end price fell 50.9% over the 10 years through Oct 2026, a compound annual decline of 6.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $6.35 in Oct 2016 and its lowest $0.67 in Aug 2017, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ANIX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ANIX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.7%, and over 6 months it fell 7.6%. The month-end price fell 1.3% over the 3 years through Oct 2026, a compound annual decline of 0.4%.

    PeriodChange
    1 month-4.5%
    3 months-25.7%
    6 months-7.6%
    12 months-41.9%
    12 months, with dividends-41.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-1.3%-0.4%
    5 years-34.6%-8.1%
    10 years-50.9%-6.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 66.9%, and its weakest was 2017, when it fell 56.3%.

    YearCloseChange
    2026 through Oct 2026$3.120.0%
    2025$3.12+34.5%
    2024$2.32-40.2%
    2023$3.88-8.7%
    2022$4.25+43.1%
    2021$2.97-3.3%
    2020$3.07-6.4%
    2019$3.28-16.8%
    2018$3.94+66.9%
    2017$2.36-56.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 11.1% below its 50-day average of $2.87 and 13.7% below its 200-day average of $2.96.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.55
    52-week high$5.46-53.3%
    52-week low$2.32+9.9%
    50-day average$2.87-11.1%
    200-day average$2.96-13.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 57.6%.

    MeasureValue
    1-year beta1.50
    Largest fall, 1 year-55.0%
    Largest fall, 3 years-57.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ANIX

    What is ANIX's 1-year price change?

    Anixa Biosciences's price fell 41.9% over the past 12 months. With dividends included, the 12-month total return was -41.9%.

    What is ANIX's 5-year price change?

    Anixa Biosciences's month-end price fell 34.6% over the 5 years through Oct 2026, a compound annual decline of 8.1%. These figures leave out dividends.

    What is ANIX's 52-week high and low?

    Anixa Biosciences's 52-week high is $5.46 and its 52-week low is $2.32. Its latest price of $2.55 on Nov 17, 2026 is 53.3% below the high.

    What is ANIX's beta?

    Anixa Biosciences's 1-year beta against the S&P 500 is 1.50, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 55.0%.

    Is the ANIX chart free?

    Yes. Advanced Charting for ANIX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.